Webinar: Germany’s Medical Research Act: A Game-Changer for EU Clinical Trials
6 June 2025 | 3:30PM (CEST)
Webinar: Germany’s Medical Research Act: A Game-Changer for EU Clinical Trials
6 June 2025 | 3:30PM (CEST)
Are you ready to explore how Germany’s new Medical Research Act will reshape the European clinical trial landscape? This groundbreaking reform is designed to streamline approvals, reduce bureaucracy, and accelerate trial execution – unlocking Germany’s full potential as a key hub for innovation, with lessons to be learned for global trial organizers.
Join experts from vfa, Boehringer Ingelheim, Sanofi, BMS and Clariness as we break down:
- How the new framework improves trial efficiency
- What this means for patient recruitment & retention
- Practical insights on leveraging Germany for your global trial strategy
Date & time: 6 June 2025, 3:30pm (CEST)
Location: Live webinar (online)
Language: English
Don’t miss this opportunity to stay ahead of regulatory changes and optimize your clinical trial footprint in Europe. Register now!
Speakers
We will be joined by guest speakers from international sponsors, with different regional headquarters, offering a varied viewpoint, including:
Speakers:
- Dr. Michael Busse, Head of Clinical Research at Boehringer Ingelheim (HQ in Germany)
- Dr. Katrin Roscher, Head Clinical Study Unit GSA at Sanofi (HQ in France)
- Dr. Susanne Busta, Head of Clinical Operations DACH at Bristol Myers Squibb (HQ USA)
- Dr. Thorsten Ruppert, Senior Manager Research, Development and Innovation at the vfa (National association for German pharmaceuticals)
- Moritz Kloss, SVP Registry & Local Markets, Clariness
Agenda
- Welcome & Introduction (5 min)
- Keynote: The Medical Research Act – What’s Changing? (10 mins)
- Industry Perspective on Implementation from guest sponsors (15 mins)
- Panel discussion / Live Q&A: Unlocking Germany’s Potential for Clinical Trials (30 mins)
- Closing Remarks & Key Takeaways (5 mins)